Total Payments
$1,808
2023 Payments
$154.16
Companies
14
Transactions
44
Medicare Patients
3,326
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$1,808 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,808 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $477.05 | 7 | $0 (2023) |
| Abbott Laboratories | $469.60 | 4 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $399.74 | 7 | $0 (2021) |
| GlaxoSmithKline, LLC. | $108.52 | 7 | $0 (2020) |
| Allergan Inc. | $82.01 | 6 | $0 (2019) |
| La Jolla Pharmaceutical Company | $80.41 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $53.37 | 4 | $0 (2019) |
| Gilead Sciences, Inc. | $26.73 | 1 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $22.47 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $20.98 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $154.16 | 2 | Abbott Laboratories ($128.01) |
| 2022 | $353.98 | 5 | ABIOMED ($312.44) |
| 2021 | $309.58 | 2 | Abbott Laboratories ($185.61) |
| 2020 | $157.51 | 3 | ABIOMED ($138.46) |
| 2019 | $101.47 | 5 | Actelion Pharmaceuticals US, Inc. ($33.16) |
| 2018 | $398.27 | 19 | Actelion Pharmaceuticals US, Inc. ($100.89) |
| 2017 | $332.62 | 8 | Actelion Pharmaceuticals US, Inc. ($141.72) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $128.01 | General |
| Category: Heart Failure | ||||||
| 04/07/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $137.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/14/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $135.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/27/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/31/2022 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $41.54 | General |
| Category: Heart Failure | ||||||
| 10/18/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $185.61 | General |
| Category: Heart Failure | ||||||
| 08/04/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Cardiology | ||||||
| 10/28/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/28/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2020 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $119.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/25/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $33.16 | General |
| 01/10/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.73 | General |
| 01/09/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/02/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/24/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/09/2018 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: GIAPREZA | ||||||
| 08/08/2018 | Philips Electronics North America Corporation | Personal Care Undiv (Device) | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: RESPIRATORY | ||||||
| 07/24/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 579 | 1,878 | $457,075 | $294,175 |
| 2022 | 8 | 706 | 1,855 | $398,450 | $256,793 |
| 2021 | 10 | 916 | 2,101 | $422,125 | $272,828 |
| 2020 | 10 | 1,125 | 2,867 | $563,925 | $359,396 |
Total Patients
3,326
Total Services
8,701
Medicare Billing
$1.2M
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 267 | 1,467 | $403,425 | $257,386 | 63.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 192 | $19,200 | $13,346 | 69.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 107 | $13,375 | $10,596 | 79.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 37 | $5,550 | $3,776 | 68.0% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 19 | 33 | $6,600 | $3,537 | 53.6% |
| 31600 | Incision of windpipe for insertion of breathing tube (older than 2 years) | Facility | 2023 | 11 | 11 | $4,675 | $2,723 | 58.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 16 | $2,000 | $1,410 | 70.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,250 | $1,401 | 62.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 243 | 1,158 | $318,450 | $205,646 | 64.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 362 | $36,200 | $23,389 | 64.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 110 | 164 | $20,500 | $13,636 | 66.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 36 | $5,400 | $3,732 | 69.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 62 | $6,200 | $3,593 | 58.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $5,100 | $2,924 | 57.3% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2022 | 15 | 23 | $4,600 | $2,459 | 53.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 13 | 16 | $2,000 | $1,413 | 70.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 290 | 1,115 | $306,625 | $202,096 | 65.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 286 | 480 | $48,000 | $29,437 | 61.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 128 | 208 | $26,000 | $17,737 | 68.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 66 | $9,900 | $6,473 | 65.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 43 | 87 | $8,700 | $5,239 | 60.2% |
| 31622 | Diagnostic examination of lung airways using an endoscope | Facility | 2021 | 19 | 43 | $8,600 | $4,674 | 54.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 37 | 37 | $5,550 | $2,923 | 52.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $3,400 | $2,263 | 66.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 32 | 34 | $2,550 | $1,019 | 39.9% |
About Dr. Jeffry Jones, MD
Dr. Jeffry Jones, MD is a Pulmonary Disease healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194816272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffry Jones, MD has received a total of $1,808 in payments from pharmaceutical and medical device companies, with $154.16 received in 2023. These payments were reported across 44 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,808).
As a Medicare-enrolled provider, Jones has provided services to 3,326 Medicare beneficiaries, totaling 8,701 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Sacramento, CA
- Active Since 09/27/2006
- Last Updated 04/10/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194816272
Products in Payments
- Impella (Device) $477.05
- OPSUMIT MACITENTAN (Drug) $242.61
- CardioMEMS HF System (Device) $185.61
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $128.01
- UPTRAVI (Drug) $123.97
- Circulatory Support (Device) $114.44
- GIAPREZA (Drug) $80.41
- AVYCAZ (Drug) $67.03
- TRELEGY ELLIPTA (Drug) $55.81
- NUCALA (Biological) $52.71
- ZERBAXA (Drug) $42.09
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $41.54
- Adempas (Drug) $22.47
- FASENRA (Drug) $20.98
- Cresemba (Drug) $18.46
- UTIBRON (Drug) $18.02
- Esbriet (Biological) $17.24
- TEFLARO (Drug) $14.98
- Personal Care Undiv (Device) $12.99
- ZINPLAVA (Biological) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Sacramento
Dr. Chinh Phan, D.o, D.O
Pulmonary Disease — Payments: $365,929
Pulmonary Disease $365,929
Dr. Brooks Kuhn, M.d, M.D
Pulmonary Disease — Payments: $165,983
Pulmonary Disease $165,983
Muhammad Afzal, M.d, M.D
Pulmonary Disease — Payments: $99,668
Pulmonary Disease $99,668
Dr. Amir Zeki, Md, MD
Pulmonary Disease — Payments: $96,617
Pulmonary Disease $96,617
Brian Morrissey, Md, MD
Pulmonary Disease — Payments: $73,965
Pulmonary Disease $73,965
Dr. Eman Albaddawi, M.d, M.D
Pulmonary Disease — Payments: $6,015
Pulmonary Disease $6,015